Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neurometrix Inc
(NQ:
NURO
)
3.870
+0.070 (+1.84%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Sep 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Neurometrix Inc
< Previous
1
2
3
4
5
6
Next >
21 Stocks Moving in Thursday's Pre-Market Session
July 22, 2021
Gainers PainReform Ltd (NASDAQ: PRFX) shares rose 123% to $7.00 in pre-market trading. Second Sight Medical Products Inc (NASDAQ: EYES) shares rose 29% to $5.57 in pre-market...
Via
Benzinga
61 Biggest Movers From Yesterday
July 22, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares surged 159.2% to close at $5.34 on Wednesday after the company received a $28.3 million purchase order from Brazil's...
Via
Benzinga
Why NeuroMetrix Shares Are Skyrocketing Today
July 21, 2021
NeuroMetrix (NASDAQ:NURO) shares are trading higher by 153...
Via
Benzinga
Earnings Scheduled For July 22, 2021
July 22, 2021
Companies Reporting Before The Bell • Champions Oncology, Inc. - Common Stock (NASDAQ:CSBR) is estimated to report earnings for its fourth quarter. • MarineMax,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
July 21, 2021
Gainers Second Sight Medical (NASDAQ:EYES
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps 250 Points; Sleep Number Shares Slide After Q2 Results
July 21, 2021
Toward the end of trading Wednesday, the Dow traded up 0.73% to 34,765.42 while the NASDAQ rose 0.66% to 14,594.38. The S&P also rose, gaining 0.69% to 4,352.90. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
NeuroMetrix Stock Skyrockets On FDA Update: Technical Levels To Watch
July 21, 2021
Neurometrix Inc. (NASDAQ:NURO) shares flew higher Tuesday ...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 21, 2021
Gainers Chembio Diagnostics (NASDAQ:CEMI) stock rose 189.72% to $5.97 during Wednesday's regular session. Trading volume for Chembio Diagnostics's stock is 265.3...
Via
Benzinga
Mid-Day Market Update: Crude Oil Up 4%; Chembio Diagnostics Shares Spike Higher
July 21, 2021
Midway through trading Wednesday, the Dow traded up 0.79% to 34,785.02 while the NASDAQ rose 0.59% to 14,584.15. The S&P also rose, gaining 0.70% to 4,353.50. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
38 Stocks Moving In Wednesday's Mid-Day Session
July 21, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares jumped 218.7% to $6.57 after the company received a $28.3 million purchase order from Brazil's Bio-Manguinhos to...
Via
Benzinga
NURO Stock: Why Reddit Traders Are Targeting Red-Hot NeuroMetrix Today
July 21, 2021
NURO stock is continuing its price-doubling into today. Retail investors have caught wind of NURO short selling and flocked to buy in.
Via
InvestorPlace
Mid-Morning Market Update: Markets Open Higher; Coca-Cola Tops Q2 Views
July 21, 2021
Following the market opening Wednesday, the Dow traded up 0.62% to 34,727.53 while the NASDAQ rose 0.40% to 14,557.04. The S&P also rose, gaining 0.52% to 4,345.65. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
July 21, 2021
Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million....
Via
Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
July 21, 2021
Gainers Chembio Diagnostics, Inc. (NASDAQ: CEMI) shares rose 78.2% to $3.67 in pre-market trading after dropping more than 16% on Tuesday. Chembio’s filing recently showed...
Via
Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
July 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...
Via
Benzinga
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher
July 20, 2021
Toward the end of trading Tuesday, the Dow traded up 1.83% to 34,583.56 while the NASDAQ rose 1.74% to 14,523.41. The S&P also rose, gaining 1.70% to 4,330.82. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
62 Biggest Movers From Yesterday
July 21, 2021
Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares surged 208% to settle at $10.04 on Tuesday as the company said it received FDA breakthrough device designation for the treatment...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 20, 2021
Gainers NeuroMetrix (NASDAQ:NURO) shares moved upwards by 177.6% to $9.05 during Tuesday's regular session. As of 12:30 EST, NeuroMetrix's stock is trading at a...
Via
Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
July 20, 2021
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares climbed 50.9% to $4.2550. NeuroMetrix, Inc. (NASDAQ: NURO) gained 37.4% to $4.4750 as the company said it received FDA...
Via
Benzinga
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia
July 20, 2021
NeuroMetrix Inc's (NASDAQ: NURO) Quell device has received Breakthrough Designation from the FDA to treat fibromyalgia symptoms in adults. Fibromyalgia is a...
Via
Benzinga
Exposures
Product Safety
NURO Stock: The ‘Breakthrough’ News Rocketing NeuroMetrix Shares Higher Today
July 20, 2021
NeuroMetrix (NURO) stock is surging higher on Tuesday after getting "Breakthrough Device Designation" from the FDA for Quell.
Via
InvestorPlace
Exposures
Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week stoked rate hike fears,...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs
July 18, 2021
Biotech stocks were down for a second week in a row, as they retreated along with the broader market amid macro concerns. Consumer price inflation data released during the week...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 30, 2021
Gainers BioLine Rx (NASDAQ:BLRX) stock i...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 15, 2021
Gainers NeuroMetrix (NASDAQ:NURO) stock r...
Via
Benzinga
NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial
June 09, 2021
NeuroMetrix Inc (NASDAQ: NURO) has reported that top-line results from a randomized controlled trial of Quell for fibromyalgia will be presented at two upcoming...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 26, 2021
Gainers Zosano Pharma (NASDAQ:ZSAN) stock...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
May 21, 2021
Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago....
Via
Benzinga
21 Stocks Moving in Friday's Pre-Market Session
May 21, 2021
Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) rose 13.2% to $2.75 in pre-market trading after climbing over 11% on Thursday. The company recently reported a Q1 loss of $0.20...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.